GAMMA Investing
OVID icon

GAMMA Investing’s Ovid Therapeutics OVID Stock Holding History

GAMMA Investing’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.44K Buy
+1,381
New +$3.61K ﹤0.01% 3791

Other funds holding OVID

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing's OVID Position: Q3 2026 in Review

GAMMA Investing opened a new position in Ovid Therapeutics (OVID) in Q3 2026: 1,381 shares worth $3.44K. The stake represents ﹤0.01% of the portfolio and ranks #3791 among its holdings.

6 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • GAMMA Investing held 1,381 shares of Ovid Therapeutics worth $3.44K as of Q3 2026.
  • Ovid Therapeutics was a new GAMMA Investing position in Q3 2026.
  • Ovid Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3791 holding.
  • 6 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.